Feedback / Questions
lenamilast (ITG-1052) - Transpire Bio
https://www.manilatimes.net/2025/06/03/tmt-newswire/globenewswire/transpire-bio-enters-into-exclusive-license-agreement-with-suzhou-intragrand-pharma-for-investigational-pde4-inhibitor/2126382
 
Jun 3, 2025
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious